Papapetropoulos Spyros, Gelfand Jeffrey M, Konno Takuya, Ikeuchi Takeshi, Pontius Angela, Meier Andreas, Foroutan Farid, Wszolek Zbigniew K
Vigil Neuroscience, Inc., Watertown, MA, United States.
UCSF Medical Center, San Francisco, CA, United States.
Front Neurol. 2024 Mar 11;15:1320663. doi: 10.3389/fneur.2024.1320663. eCollection 2024.
Because adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a rare, rapidly progressive, debilitating, and ultimately fatal neurodegenerative disease, a rapid and accurate diagnosis is critical. This analysis examined the frequency of initial misdiagnosis of ALSP via comprehensive review of peer-reviewed published cases.
Data were extracted from a MEDLINE search via PubMed (January 1, 1980, through March 22, 2022) from eligible published case reports/series for patients with an ALSP diagnosis that had been confirmed by testing for the colony-stimulating factor-1 receptor gene () mutation. Patient demographics, clinical symptoms, brain imaging, and initial diagnosis data were summarized descriptively. Categorical data for patient demographics, symptoms, and brain imaging were stratified by initial diagnosis category to test for differences in initial diagnosis based on each variable.
Data were extracted from a cohort of 291 patients with ALSP from 93 published case reports and case series. Mean (standard deviation) age of symptom onset was 43.2 (11.6) years. A family history of ALSP was observed in 59.1% of patients. Cognitive impairment (47.1%) and behavioral and psychiatric abnormalities (26.8%) were the most frequently reported initial symptoms. Of 291 total cases, an accurate initial diagnosis of ALSP was made in 72 cases (24.7%) and the most frequent initial misdiagnosis categories were frontotemporal dementia (28 [9.6%]) and multiple sclerosis (21 [7.2%]). Of the 219 cases (75.3%) that were initially mis- or undiagnosed, 206 cases (94.1%) were later confirmed as ALSP by immunohistology, imaging, and/or genetic testing; for the remaining 13 cases, no final diagnosis was reported. Initial diagnosis category varied based on age, family history, geographic region, mode of inheritance, and presenting symptoms of pyramidal or extrapyramidal motor dysfunction, behavioral and psychiatric abnormalities, cognitive impairment, and speech difficulty. Brain imaging abnormalities were common, and initial diagnosis category was significantly associated with white matter hyperintensities, white matter calcifications, and ventricular enlargement.
In this literature analysis, ALSP was frequently misdiagnosed. Improving awareness of this condition and distinguishing it from other conditions with overlapping presenting symptoms is important for timely management of a rapidly progressive disease such as ALSP.
成人起病的轴突球状体和色素性神经胶质细胞白质脑病(ALSP)是一种罕见、快速进展、使人衰弱并最终致命的神经退行性疾病,快速准确的诊断至关重要。本分析通过全面回顾同行评审发表的病例,研究了ALSP初始误诊的频率。
通过PubMed对MEDLINE进行检索(1980年1月1日至2022年3月22日),从符合条件的已发表病例报告/系列中提取数据,这些病例报告/系列中的患者经集落刺激因子1受体基因()突变检测确诊为ALSP。对患者的人口统计学、临床症状、脑成像和初始诊断数据进行描述性总结。将患者人口统计学、症状和脑成像的分类数据按初始诊断类别分层,以检验基于每个变量的初始诊断差异。
从93篇已发表的病例报告和病例系列中的291例ALSP患者队列中提取数据。症状出现的平均(标准差)年龄为43.2(11.6)岁。59.1%的患者有ALSP家族史。认知障碍(47.1%)以及行为和精神异常(26.8%)是最常报告的初始症状。在291例总病例中,72例(24.7%)被准确初始诊断为ALSP,最常见的初始误诊类别是额颞叶痴呆(28例[9.6%])和多发性硬化症(21例[7.2%])。在最初误诊或未诊断的219例(75.3%)病例中,206例(94.1%)后来通过免疫组织化学、成像和/或基因检测确诊为ALSP;其余13例未报告最终诊断结果。初始诊断类别因年龄、家族史、地理区域、遗传方式以及锥体束或锥体外系运动功能障碍、行为和精神异常、认知障碍及言语困难等表现症状而异。脑成像异常很常见,初始诊断类别与白质高信号、白质钙化和脑室扩大显著相关。
在本文献分析中,ALSP经常被误诊。提高对这种疾病的认识并将其与具有重叠表现症状的其他疾病区分开来,对于及时管理像ALSP这样快速进展的疾病很重要。